Genmab A/S (GMAB) released earnings for full year that Dropped, from the same period last year
The company's bottom line totaled $963 million, or $15.37 per share. This compares with $1.133 billion, or $17.53 per share, last year.
The company's revenue for the period rose 19.2% to $3.720 billion from $3.121 billion last year.
Genmab A/S earnings at a glance (GAAP) :
-Earnings: $963 Mln. vs. $1.133 Bln. last year.-EPS: $15.37 vs. $17.53 last year.-Revenue: $3.720 Bln vs. $3.121 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.